On May 22, 2024 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that management will participate in a virtual fireside chat at the TD Cowen 5TH Annual Oncology Innovation Summit on Tuesday, May 28, 2024 at 3:20 PM ET (Press release, UroGen Pharma, MAY 22, 2024, View Source/news-releases/news-release-details/urogen-pharma-present-td-cowen-5th-annual-oncology-innovation" target="_blank" title="View Source/news-releases/news-release-details/urogen-pharma-present-td-cowen-5th-annual-oncology-innovation" rel="nofollow">View Source [SID1234643537]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the fireside chat can be accessed by visiting the Events and Presentations Section of the Company’s website: View Source